Monitor for NDA submission details and potential partnership/licensing announcements. The stock may gap up on the beat but could fade if no new binary catalysts emerge.
Price Chart
Executive Summary
Monopar reported Q1 2026 EPS of -$0.46, beating consensus of -$0.90 by 48.9%, driven by lower-than-expected operating expenses and higher interest income. The company reiterated its mid-2026 NDA submission for ALXN1840 in Wilson disease and reported $137.5M cash, sufficient through at least 2027.
Key Financial Metrics
Key Facts
- Q1 2026 EPS -$0.46 vs consensus -$0.90 (48.9% beat)
- Net loss $3.9M vs $2.6M in Q1 2025, driven by higher R&D spend
- Cash $137.5M as of March 31, 2026, sufficient through at least Dec 2027
- NDA submission for ALXN1840 (Wilson disease) on track for mid-2026
- Interest income $1.33M vs $0.60M in Q1 2025, boosted by $91.9M capital raise proceeds
Financial Impact
EPS beat of 48.9% on a -$0.90 consensus; cash runway extended through 2027; no revenue generated
Risk Factors
- NDA submission may face delays or regulatory setbacks
- Pre-revenue biotech with no approved products; cash burn rate increasing
- Dilution risk from future capital raises to fund commercialization
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3295273 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | Institutional Cluster | $72.00 | awaiting T+60 | — | $71.84 (−0.22%) |
Oct 27, 2026 today | SC 13G | $72.00 | awaiting T+60 | — | $71.84 (−0.22%) |
Oct 5, 2026 22d ago | Insider Cluster | $79.57 | awaiting T+60 | — | $71.84 (+9.71%) |
Oct 1, 2026 26d ago | 144 | $77.97 | awaiting T+60 | — | $71.84 (−7.86%) |
Aug 28, 2026 8w ago | Insider Cluster | $111.93 | awaiting T+60 | — | $71.84 (−35.82%) |
Aug 27, 2026 8w ago | Insider Cluster | $111.89 | awaiting T+60 | — | $71.84 (−35.79%) |
Aug 25, 2026 9w ago | 144 | $113.72 | awaiting T+60 | — | $71.84 (−36.83%) |
Aug 12, 2026 10w ago | 8-K | $114.90 | awaiting T+60 | — | $71.84 (−37.48%) |
Aug 12, 2026 10w ago | Press Release | $114.90 | awaiting T+60 | — | $71.84 (−37.48%) |
Jul 22, 2026 13w ago | 8-K | $112.48 $71.80 | ▼ −36.17% | ▼ −39.43% | $71.84 (−36.13%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers